 |  | www.andropause.org.uk |
 | ||
 | ||
 | ||
| ||
 |  | |
|  | |
|  | |
|  | |
|  | |
|  | |
|  | |
 | ||
 | ||
 | ||
 | ||
 | ||
| Conference 2003 |  |
TOWARDS THE PERFECT ANDROGEN: A CUSTOMIZED APPROACH TO TREATMENT OPTIONS Dr. Bruce Biundo, Pharmacy Consultant, Professional Compounding Centres of America, USA . This presentation will discuss choosing the right treatment for the right
patient.. Many clinicians seem to make treatment choices by looking at available
commercial products, then attempting to fit the patient’s hormone
supplementation with those products. In
reality, it is feasible and attractive to
design a treatment protocol that fits the needs of an individual patient. All
patients do not respond to the same dose, nor to the same dosage form. In this presentation, the various treatment options will be discussed,
along with means of customizing the treatment for the patient. Today, many pharmacists
who are knowledgeable in pharmacokinetics are learning about screenings, patient
referrals to physicians, and treatment options for andropausal men. A new model
for collaborative relationships between physicians and pharmacists is coming into
existence, and, as a result, many patients are being successfully treated with
dosage forms and doses that are individually determined. Buccal linguets, sublingual
tablets and drops, injections, pellets, topical creams, gels and lotions are some
of the ways that support individual dosage form and dose titration. In addition to testosterone, the use of aromatase inhibitors, prohormones,
and nutritional support will be discussed. Dr. Bruce Biundo, PhD Pharmacy consultant, Houston, Texas, USA. Email: b.biundo@pcarrx,com Bruce Biundo is a consultant pharmacist with Professional Compounding
Centers of America, an international company based in Houston, Texas. He has a special interest in men's health, and has developed a seminar
on andropause designed for the education of physicians and pharmacists. He works
with health care professionals all over the U.S. in exploring this new science,
and lectures on andropause for PCCA on an on-going basis. | |